Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             30 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen Schultz, Marcus J

9 9 p. 939-941
artikel
2 BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers Lustig, Yaniv

9 9 p. 999-1009
artikel
3 Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study Estenssoro, Elisa

9 9 p. 989-998
artikel
4 Correction to Lancet Respir Med 2021; published online June 11. https://doi.org/10.1016/S2213-2600(21)00214-9
9 9 p. e95
artikel
5 Correction to Lancet Respir Med 2021; published online June 18. https://doi.org/10.1016/S2213-2600(21)00089-8
9 9 p. e95
artikel
6 COVID-19 and the mental health of children with respiratory illness Sinha, Ian P

9 9 p. 952-954
artikel
7 COVID-19, smoking, and cancer: a dangerous liaison The Lancet Respiratory Medicine,

9 9 p. 937
artikel
8 Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Butler, Christopher C

9 9 p. 1010-1020
artikel
9 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Spagnolo, Paolo

9 9 p. 1065-1076
artikel
10 Elisa Estenssoro: a career devoted to critical care Kirby, Tony

9 9 p. 951-952
artikel
11 Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
9 9 p. 1030-1049
artikel
12 Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial He, Jianxing

9 9 p. 1021-1029
artikel
13 Imatinib in COVID-19: hope and caution Bernal-Bello, David

9 9 p. 938-939
artikel
14 Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial Aman, Jurjan

9 9 p. 957-968
artikel
15 Implications of the second wave of COVID-19 in India Asrani, Purva

9 9 p. e93-e94
artikel
16 Living with severe asthma since childhood Kirby, Tony

9 9 p. 950-951
artikel
17 Long-term safety of lumacaftor–ivacaftor in children aged 2–5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study Hoppe, Jordana E

9 9 p. 977-988
artikel
18 Lung transplantation for COVID-19-associated ARDS Messika, Jonathan

9 9 p. e89
artikel
19 Lung transplantation for COVID-19-associated ARDS Lepper, Philipp M

9 9 p. e88
artikel
20 Lung transplantation for COVID-19-associated ARDS – Authors' reply Bharat, Ankit

9 9 p. e90
artikel
21 Moving from collective to distributed epidemiological cancer research Matsuda, Tomohiro

9 9 p. 945-947
artikel
22 Population science with individual-level data make for better policies Bar-Zeev, Naor

9 9 p. 942-943
artikel
23 PRINCIPLE: a community-based COVID-19 platform trial Macleod, John

9 9 p. 943-945
artikel
24 Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease Mackintosh, John A

9 9 p. 947-949
artikel
25 Stigma: an unmet public health priority in COPD Mathioudakis, Alexander G

9 9 p. 955-956
artikel
26 The breath of life Thorley, Jennifer

9 9 p. 954-955
artikel
27 Time to move away from an oxygen-centric model of pulmonary infarction? Cherian, Robin

9 9 p. e91
artikel
28 Time to move away from an oxygen-centric model of pulmonary infarction? – Authors' reply McGonagle, Dennis

9 9 p. e92
artikel
29 Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study Calabrò, Luana

9 9 p. 969-976
artikel
30 Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement Chaddha, Udit

9 9 p. 1050-1064
artikel
                             30 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland